Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · CBD

Is CBD legal in Germany?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Cannabidiol is expressly outside the statutory definition of Cannabis. [Certain] Re-derived in this pass: KCanG S 1 Nr. 8 was read at gesetze-im-internet.de on 21 September 2026. It defines Cannabis and then excepts five things by letter, and Buchstabe b is Cannabidiol. So CBD is not reached by the Konsumcannabisgesetz as cannabis, and it is not reached by the Betaeubungsmittelgesetz either, because the BtMG Anlagen do not name it. CBD (cannabidiol) as an isolated substance is not a narcotic under the Narcotics Act (BtMG), only THC is scheduled, so consumer CBD is lawful if derived from EU-certified industrial hemp within the THC field-threshold (raised from 0.2% to 0.3% by the Consumer Cannabis Act/CanG in force 1 April 2024), though ingestible CBD requires Novel Food authorisation, which the BVL treats as not yet met.
Consequences if caught
Capital exposure: none. Germany has no death penalty and neither statute carries a life term. Compliant CBD carries no offence. [Certain] Re-derived in this pass from KCanG S 1 Nr. 8 read at gesetze-im-internet.de on 21 September 2026: Cannabidiol is excepted from the Cannabis definition at Buchstabe b, so the product itself is not cannabis. A CBD product carrying more than trace delta-9-tetrahydrocannabinol is caught through its THC content rather than through the CBD, and since 1 April 2024 that route runs through the Konsumcannabisgesetz and not through the Betaeubungsmittelgesetz: BtMG Anlage I was read the same day and lists the isomers Delta-6a(10a), Delta-6a, Delta-7, Delta-8, Delta-10 and Delta-9(11) and NOT Delta-9. [Likely] Carried forward from the published entry and not re-derived in this pass: the industrial-hemp field threshold was raised from 0.2% to 0.3%, and ingestible CBD requires Novel Food authorisation which the BVL treats as not yet met.
If prescribed or medical
Cannabidiol medicines such as Epidyolex are prescribable; ingestible CBD may otherwise be placed only via a medicinal-product or Novel Food authorisation. Distinct from cannabis, which was delisted from the BtMG for adult use by the CanG on 1 April 2024.
Documentation
Carry proof the product is EU-certified-hemp derived and within the THC limit; no personal-import licence is needed for compliant consumer CBD, and cannabidiol medicines require a prescription.
Primary sources
  • bvl.bund.de
  • Provenance of this revision: the Cannabidiol exception was re-derived in this pass from Konsumcannabisgesetz S 1 Nr. 8 Buchstabe b at https://www.gesetze-im-internet.de/kcang/__1.html and the tetrahydrocannabinol isomer list from https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html, both read as at 21 September 2026. The earlier entry's statement that a THC-bearing CBD product is caught under the Betaeubungsmittelgesetz predates the 1 April 2024 split and is superseded. The hemp-threshold and Novel Food statements are carried forward and were not re-derived.

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Germany

Same substance, other countries